Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays a 403 Forbidden error with the site header and footer visible, replacing the prior study record content.SummaryDifference19%

- Check37 days agoChange DetectedThe page's revision label updated from v3.6.5 to v3.6.6, indicating a new page revision for the study entry.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision tag on the page updated from v3.6.4 to v3.6.5, replacing the previous version in the revision history to indicate a small update to the page’s version tag.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4. This indicates a new release of the page without changes to study content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3. This indicates an updated build/version of the ClinicalTrials.gov page without changes to its content or data.SummaryDifference0.1%

- Check101 days agoChange DetectedPlatform revision updated from v3.6.0 to v3.6.2, indicating an updated build of the site. This change does not modify study data or visible content on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.